Since 1993, OrbiMed has been an active investor in venture capital. Our team has helped to start, nurture and commercialize some of today's most successful health sciences companies. OrbiMed seeks to be the capital provider of choice to life sciences companies seeking growth and new opportunities. The following companies represent our current portfolio of private equity investments:

	Acceleron Pharma Developing therapeutics for metabolic and musculoskeletal diseases affecting millions of people.  Learn more
	Affimed Discovering and developing next generation antibody therapies  Learn more
	Amarin Discovering and developing novel treatments for central nervous system and cardiovascular diseases  Learn more
	Ambit Biosciences Discovering and developing small-molecule kinase inhibitors for the treatment of cancer  Learn more
	Amnis Corporation Commercializing innovative cellular imaging technologies  Learn more
	Apoptos Discovering and developing novel anticancer drugs that activate apoptosis  Learn more
	Arius Research Discovering novel anticancer monoclonal antibodies  Learn more
	ARYx Pioneering retro-metabolic drug discovery and development  Learn more
	Athersys Developing and commercializing novel treatments for obesity, cognitive and attention/sleep disorders  Learn more
	Avanir Pharmaceuticals Engaged in research, discovery and development of innovative drug products  Learn more
	BioCryst Utilizing structure-based drug design to develop new products  Learn more
	Biodel Developing drug delivery technologies that increase drug efficacy and tolerability  Learn more
	CeraPedics Developing and commercializing products for the orthopedic bone substitutes market  Learn more
	Cerenis Therapeutics Discovering and developing breakthrough HDL-related therapies for the treatment of cardiovascular and metabolic diseases  Learn more
	Cerimon Pharmaceuticals Developing therapies for pain, inflammation & autoimmune disease  Learn more
	ChemoCentryx A drug discovery and development company focused on the immune system.  Learn more
	Emphasys Medical Developing minimally invasive therapies to benefit patients with pulmonary disease  Learn more
	Enobia Developing therapeutics for the treatment of bone disorders  Learn more
	Innovative Spinal Technologies Developing next-generation spinal therapies  Learn more
	Insulet Developing novel medical devices for treatment of diabetes  Learn more
	InteKrin Therapeutics Developing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders  Learn more
	MacroGenics Developing novel immunotherapeutics across multiple diseases  Learn more
	NeurAxon Discovering and developing next generation pain therapeutics  Learn more
	NxStage Medical Commercializing products to significantly improve renal care  Learn more
	Pieris AG Discovering and developing Anticalins®, a novel class of targeted protein therapeutics  Learn more
	Sapphire Therapeutics Developing and commercializing promising compounds for treatment of oncologic and metabolic diseases. promising compounds for treatment of oncologic and metabolic diseases.  Learn more
	Sientra, Inc. Developing products for the plastic surgery and aesthetics markets  Learn more
	Singulex Developing and commercializing the next generation of biomarker discovery and validation technologies  Learn more
	superDimension Providing minimally-invasive diagnosis and treatment of lung disease via endoscopic tools  Learn more
	Supernus Pharmaceuticals Leveraging unique drug delivery expertise to develop specialty pharmaceutical products  Learn more
	Targanta Therapeutics Developing and commercializing novel antibacterial agents  Learn more
	ViewRay Developing next generation radiotherapy technologies  Learn more
	VIVUS, Inc. Developing next-generation treatments for obesity and sexual health  Learn more
	Volcano Therapeutics, Inc. A leading manufacturer of intravascular ultrasound catheters and functional measurement guidewires  Learn more